Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Biora Therapeutics ( (BIOR) ) has issued an announcement.
Biora Therapeutics faced potential delisting from Nasdaq due to failing to meet the market value of listed securities (MVLS) and market value of publicly held shares (MVPHS) requirements. Despite receiving an extension to comply with Nasdaq rules, the company must demonstrate compliance by December 9, 2024, to maintain its listing. At a special meeting, stockholders approved key proposals related to issuing common stock and amending the company’s 2018 Plan, reflecting efforts to address compliance challenges.
See more data about BIOR stock on TipRanks’ Stock Analysis page.
